rAAV-Olig001-ASPA Gene Therapy

· Myrtelle Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAAV-Olig001-ASPA Gene Therapy, covering 2025-11-14 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease [Phase 1, Phase 2]